Literature DB >> 7286594

Infection with the delta agent in chronic HBsAg carriers.

A Smedile, P Dentico, A Zanetti, E Sagnelli, E Nordenfelt, G C Actis, M Rizzetto.   

Abstract

To establish the mechanism of progression to chronicity of the HBsAg-associated delta infection, serum hepatitis B virus and delta markers were tested in five babies born to HBsAg-positive mothers with anti-delta, in 42 follow-up patients with acute hepatitis B virus and delta hepatitis, and in collections of sera from 8 HBsAg carriers with anti-delta. Evidence of delta infection was found in the baby born to a mother with serum HBeAg and in none of the four babies born to mothers with anti-HBe. Hepatitis was self-limited in the 42 patients acutely infected by hepatitis B virus and delta agent; none developed persistent HBs-antigenemia and the majority displayed transient anti-delta of IgM class. In seven HBsAg carriers high titers of anti-delta developed during the follow-up; coincident with the rise of the antibody, aminotransferase elevation occurred in five previously asymptomatic carriers and persisted in three of them. No sign of infectious hepatitis B virus replication was detected in five of the carriers throughout the follow-up, and all of them had anti-HBe before the rise of anti-delta and of aminotransferase. HBsAg carriers with diminished hepatitis B virus synthesis appear to be at high risk of developing chronic delta infection and disease when exposed to the delta-infectious serum of other carriers.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286594

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  Antiviral treatment in chronic infection with hepatitis B virus.

Authors:  G Alexander; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-05

Review 2.  Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.

Authors:  Nicole D Ferrante; Vincent Lo Re
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

Review 3.  Viral hepatitis: past and future of HBV and HDV.

Authors:  Emmanuel Thomas; Masato Yoneda; Eugene R Schiff
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

Review 4.  Hepatitis D virus coinfection and superinfection.

Authors:  Francesco Negro
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

5.  Hepatitis delta infections.

Authors:  K G Nicholson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

6.  Experimental transmission of the delta virus to a hepatitis B chronic carrier chimpanzee with the development of persistent delta carriage.

Authors:  H A Fields; S Govindarajan; H S Margolis; C D Schable; J W Ebert; J E Maynard
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

7.  Epidemiology of hepatitis delta virus (HDV) infection.

Authors:  A Ponzetto; B Forzani; P P Parravicini; C Hele; A Zanetti; M Rizzetto
Journal:  Eur J Epidemiol       Date:  1985-12       Impact factor: 8.082

Review 8.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

9.  Delta infection among patients with chronic hepatitis B in the Stockholm region.

Authors:  G Lindh; O Weiland; B G Hansson; A Svedmyr
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

10.  Acute type A hepatitis in three patients with chronic HBV infection.

Authors:  C Conteas; H Kao; J Rakela; B Weliky
Journal:  Dig Dis Sci       Date:  1983-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.